EVENTS, PRESENTATIONS & PUBLICATIONS
Pipeline
Building a broad portfolio of respiratory therapeutics
Patient Resources
Helping to understand and improve respiratory care
November 2024
Developing innovative therapies for the treatment of respiratory diseases
We aim to improve health and wellbeing for those affected by chronic respiratory diseases.
Latest News
Our Product
Learn more about this FDA-approved product and its novel mechanism of action.
Verona Pharma announces the FDA approval of Ohtuvayre™ (ensifentrine) a new inhaled treatment.
We welcome enquires from healthcare professionals.